Tamir Biotechnology, Inc.·4

Apr 30, 4:15 PM ET

WEISS PAUL M 4

4 · Tamir Biotechnology, Inc. · Filed Apr 30, 2010

Insider Transaction Report

Form 4
Period: 2010-04-28
WEISS PAUL M
Director
Transactions
  • Award

    Common Stock (Right to Buy)

    2010-04-28+125,000125,000 total
    Exercise: $0.26From: 2010-12-31Exp: 2015-12-31Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Issued under the Company's 2004 Stock Incentive Plan and qualified under Rule 16b-3(d).

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT